STOCKHOLM, Nov. 9, 2020 /PRNewswire/ -- Dr Rovira is Head of
Neuroradiology at Vall d'Hebron Hospital in Barcelona and a Professor of Radiology and
Neuroimmunology. He is specialized in diagnostic neuroradiology
with particular interest in demyelinating diseases, stroke,
neuro-oncology and head and neck tumors. He is past president of
the European Society of Neuroradiology and served as Co-Chairman of
MAGNIMS (European Multicenter Collaborative Research Network on MRI
in MS). He is on the editorial boards of Neurology, Neuroradiology
and MS Forum, and member of the International Advisory Board on
Clinical Trials in MS.
"I have collaborated with SyntheticMR for a few years now and I
am a strong believer in the benefits of quantitative MRI," says Dr
Rovira. "I look forward to working with the team at SyntheticMR to
create a robust and clinically valuable product that can benefit
our patients."
"Dr Rovira has provided valuable guidance to us at SyntheticMR
in the past, and we are pleased to welcome him to our newly
established Medical Advisory Board," says Ulrik Harrysson, CEO
SyntheticMR. "We work hard to ensure we deliver products and
features that are robust and reliable, of high quality and with
clear clinical value. Dr Rovira's extensive experience will be
important for us as we continue to develop our product within
neuroradiology."
CONTACT:
For additional information, please contact Ulrik Harrysson,
CEO, SyntheticMR AB, +46 70 529 29
87 ulrik.harrysson@syntheticmr.com
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/syntheticmr-ab/r/dr--alex-rovira-from-hospital-vall-d-hebron-joins-syntheticmr-s-medical-advisory-board,c3228728
The following files are available for download:
https://mb.cision.com/Main/11663/3228728/1329156.pdf
|
Release
|
https://news.cision.com/syntheticmr-ab/i/alex-2019,c2845130
|
Alex 2019
|
View original
content:http://www.prnewswire.com/news-releases/dr-alex-rovira-from-hospital-vall-dhebron-joins-syntheticmrs-medical-advisory-board-301168509.html
SOURCE SyntheticMR AB